Bonus BioGroup Ltd. (BBIXF)

OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
At close: Mar 25, 2025
-45.45%
Market Cap 58.05M
Revenue (ttm) n/a
Net Income (ttm) -7.64M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,900
Average Volume 6,940
Open 0.0300
Previous Close 0.0300
Day's Range 0.0300 - 0.0300
52-Week Range 0.0003 - 0.0500
Beta 0.97
RSI 49.78
Earnings Date May 29, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue d... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange OTCMKTS
Ticker Symbol BBIXF
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

There is no news available yet.